Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Clinical Data
Test Article #3
Test Fronts Teaser
Andrew Sinetar
Apr 9, 2026 12:21am
Icon, Advarra team up to optimize trials, expand access
Mar 24, 2026 4:52pm
Ocugen eye disease gene therapy nabs underwhelming ph. 2 win
Mar 24, 2026 10:40am
Shionogi pays Apnimed $100M for sleep disorder joint venture
Mar 24, 2026 9:20am
Merck hands over $20M in IBD target deal with Quotient
Mar 24, 2026 6:00am
Innovent eyes China approval after matching Eylea in phase 3
Mar 24, 2026 6:00am